Trials / Completed
CompletedNCT02146391
Study to Evaluate the Effect of Food Upon the Pharmacokinetics of Androxal
AN OPEN-LABEL, RANDOMIZED, SINGLE-DOSE, TWO-WAY CROSSOVER STUDY TO EVALUATE THE EFFECT OF FOOD UPON THE PHARMACOKINETICS OF ANDROXAL
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- Repros Therapeutics Inc. · Industry
- Sex
- Male
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
This study is an open-label, randomized, single-center, single-dose, two-way crossover study of the PK properties of Androxal in healthy male subjects. Twelve male subjects will each receive a single dose of Androxal 25 mg in both the fed and fasting state.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Androxal 25 mg Capsules |
Timeline
- Start date
- 2014-06-01
- Primary completion
- 2014-07-01
- Completion
- 2014-07-01
- First posted
- 2014-05-23
- Last updated
- 2014-08-11
Source: ClinicalTrials.gov record NCT02146391. Inclusion in this directory is not an endorsement.